Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

XAFIMED safinamide (as mesilate) 50 mg tablet blister pack - TGA Drug Approval Details

Approvals/TGA/XAFIMED safinamide (as mesilate) 50 mg tablet blister pack

Approved

STANDARD

XAFIMED safinamide (as mesilate) 50 mg tablet blister pack

Medsurge Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: Dec 9, 2025
Approval ID: ce240af55f5ac34a
Company: Medsurge Pharma Pty Ltd
Type: Standard

Approval Details

Approval Id: ce240af55f5ac34a
Product Name: XAFIMED safinamide (as mesilate) 50 mg tablet blister pack
Artg Id: 509986
Artg Name: XAFIMED safinamide (as mesilate) 50 mg tablet blister pack
Sponsor: Medsurge Pharma Pty Ltd
Artg Date: 2025-11-12
Registration Type: Medicine
Therapeutic Good Type: Medicines
Licence Status: A
Licence Category: RE

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

ce240af55f5ac34a

Type

Standard

Back to TGA Approvals